Gitel S N, Stephenson R C, Wessler S
Haemostasis. 1978;7(1):10-8. doi: 10.1159/000214227.
Estrogen-containing compounds are thrombogenic in man. The extent of thrombosis is dose-related, but a measure of this thrombogenicity is not currently available. Evidence is presented, using an animal model of venous thrombosis, that impaired Xa inhibitory activity (the rate of reaction between Xa and antithrombin III) correlates with the development of thrombosis initiated by thrombin in rabbits receiving an oral contraceptive compound. The responses in the clotting assay and in the extent of thrombosis are dose-related. The hypercoagulable state induced by oral contraceptives can be completely reversed by trace amounts of heparin.
含雌激素的化合物对人类具有致血栓形成作用。血栓形成的程度与剂量相关,但目前尚无衡量这种致血栓形成性的方法。利用静脉血栓形成的动物模型提供的证据表明,Xa抑制活性受损(Xa与抗凝血酶III之间的反应速率)与接受口服避孕药化合物的兔子中由凝血酶引发的血栓形成的发展相关。凝血试验中的反应和血栓形成的程度与剂量相关。口服避孕药诱导的高凝状态可被微量肝素完全逆转。